Hostname: page-component-76fb5796d-vfjqv Total loading time: 0 Render date: 2024-04-25T12:46:21.424Z Has data issue: false hasContentIssue false
  • English
  • Français

No Crossover Reactions to Citalopram or Paroxetine among Patients Hypersensitive to Zimeldine

Published online by Cambridge University Press:  02 January 2018

Bengt-O. Bengtsson ,
Jöns Lundmark  and
Jan Wålinder
Bengt-O. Bengtsson*
Affiliation:
Department of Psychiatry, Faculty of Health Sciences, University Hospital, S-581 85 Linköping, Sweden
Jöns Lundmark
Affiliation:
Department of Psychiatry, Faculty of Health Sciences, University Hospital, S-581 85 Linköping, Sweden
Jan Wålinder
Affiliation:
Department of Psychiatry, Faculty of Health Sciences, University Hospital, S-581 85 Linköping, Sweden
*
∗Correspondence
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Brief Reports
Information
The British Journal of Psychiatry , Volume 158 , Issue 6 , June 1991 , pp. 853 - 855
Copyright
Copyright © The Royal College of Psychiatrists 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Chouinard, G. & Jones, B. (1984) No crossover of hypersensitivity between zimeldine and fluoxetine. Canadian Medical Association Journal, 131, 1190.Google Scholar
Fagius, J., Osterman, P. O., Sidén, Å., et al (1985) Guillain-Barré syndrome following zimeldine treatment. Journal of Neurology, Neurosurgery, and Psychiatry, 48, 65–69.Google Scholar
Heel, R. C., Morley, P. A., Brogden, R. N., et al (1982) Zimeldine: a review of its pharmacological properties and therapeutic efficacy in depressive illness. Drugs, 24, 169–206.CrossRefGoogle ScholarPubMed
Huitfeldt, B. & Montgomery, S. A. (1983) Comparison between zimeldine and amitriptyline of efficacy and adverse symptoms: a combined analysis of four British clinical trials in depression. Acta Psychiatrica Scandinavica, 68 (suppl. 308), 55–69.Google Scholar
Kristofferson, A. & Nilsson, B. S. (1989) Zimeldine: febrile reactions and peripheral neuropathy. In Autoimmunity and Toxicology (eds M. E. Kammüller, N. Bloksma & W. Seinen), pp. 183–214. Amsterdam: Elsevier Science Publishers.Google Scholar
Langlois, R., Cournoyer, G., De Montigny, C., et al (1985) High incidence of multisystemic reactions to zimeldine. European Journal of Clinical Pharmacology, 28, 67–71.Google Scholar
Lundmark, J., Scheel Thomsen, I., Fjord-Larsen, T., et al (1989) Paroxetine: pharmacokinetic and antidepressant effect in the elderly. Acta Psychiatrica Scandinavica, 80 (suppl. 350), 76–80.Google Scholar
Montgomery, S. A., Gabriel, R., James, D., et al (1989) The specificity of the zimeldine reaction. International Clinical Psychopharmacology, 4, 19–23.Google Scholar
Nilsson, B. S. (1983) Adverse reactions in connection with zimeldine treatment: a review. Acta Psychiatrica Scandinavica, 68 (suppl. 308), 115–119.Google Scholar
Pottage, A. & Groschinsky-Grind, M. (1983) Cardiovascular effects of zimeldine. Acta Psychiatrica Scandinavica, 68 (suppl. 308), 125–130.Google Scholar
Thomas, K. (1989) Immunomodulation in mice induced by the antidepressant drug zimeldine. Doctoral dissertation. Research Institute of Toxicology, Section Immunotoxicology, University of Utrecht, Utrecht, The Netherlands.Google Scholar
Warborg Larsen, F. & Eggert Hansen, C. (1984) Zimeldine versus amitriptyline in endogenous depression. A double-blind study. Acta Psychiatrica Scandinavica, 69, 343–349.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.